Top

Published in:

Open Access 01-08-2015 | Psychiatry and Preclinical Psychiatric Studies - Review article

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

Authors: Krzysztof Krysta, Marek Krzystanek, Małgorzata Janas-Kozik, Adam Klasik, Irena Krupka-Matuszczyk

Published in: Journal of Neural Transmission | Special Issue 1/2015

Abstract

Anxiety and depressive disorders are characterized by a number of clinical symptoms like decreased mood, apathy, anhedonia and anxiety. An important element of the clinical picture is also neurocognitive impairment. The most common treatment methods for depression and anxiety are pharmacology, psychotherapy or a combination of both methods. The data from literature show that those treatment methods lead to an improvement of clinical symptoms, but they exert a possible impact on cognitive functions. However the study results referring both to the role of pharmacological treatment and psychotherapy in this domain are still inconsistent. There is an increasing number of accessible data confirming the positive effects of those clinical interventions on cognitive functioning of anxiety and depressive patients, but the interpretation is complicated because of differences in methodology as well as examined sample size and their characteristics. More studies are then needed to describe this phenomenon.

Asmundson GJG, Stein MB, Larsen DK, Walker JR (1995) Neurocognitive function in panic disorder and social phobia patients. Anxiety 1:201–207

Balconi M (2013) Dorsolateral prefrontal cortex, working memory and episodic memory processes: insight through transcranial magnetic stimulation techniques. Neurosci Bull 29:381–389PubMedCrossRef

Barsaglini A, Sartori G, Benetti S, Pettersson-Yeo W, Mechelli A (2013) The effects of psychotherapy on brain function: A systematic and critical review. Prog Neurobiol. doi:10.1016/j.pneurobio.2013.10.006 PubMed

Bastos AG, Guimarães LS, Trentini CM (2013) Neurocognitive changes in depressed patients in psychodynamic psychotherapy, therapy with fluoxetine and combination therapy. J Affect Disord 151:1066–1075PubMedCrossRef

Bora E, Yücel M, Pantelis C (2010) Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond. Schizophr Bull 36:36–42PubMedCentralPubMedCrossRef

Bora E, Harrison BJ, Yücel M, Pantelis C (2013) Cognitive impairment in euthymic major depressive disorder: a meta-analysis. Psychol Med 43:2017–2026PubMedCrossRef

Borkowska A, Drozdz W, Ziółkowska-Kochan M, Rybakowski J (2007) Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression. Neuropsychopharmacol Hung 9:131–136PubMed

Bowie CR, Gupta M, Holshausen K, Jokic R, Best M, Milev R (2013a) Cognitive remediation for treatment-resistant depression: effects on cognition and functioning and the role of online homework. J Nerv Ment Dis 201:680–685PubMedCrossRef

Bowie CR, Gupta M, Holshausen K (2013b) Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions. Can J Psychiatr 58:319–325

Braszko JJ, Karwowska-Polecka W, Halicka D, Gard PR (2003) Captopril and enalapril improve cognition and depressed mood in hypertensive patients. J Basic Clin Physiol Pharmacol 14:323–343PubMedCrossRef

Buchheim A, Viviani R, Kessler H, Kächele H, Cierpka M, Roth G, George C, Kernberg OF, Bruns G, Taubner S (2012) Changes in prefrontal-limbic function in major depression after 15 months of long-term psychotherapy. PLoS One 7:e33745PubMedCentralPubMedCrossRef

Castrén E (2013) Neuronal network plasticity and recovery from depression. JAMA Psychiatr 70:983–989CrossRef

Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C, Lindefors N (2012) Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Transl Psychiatr 22(2):e120CrossRef

Chang HH, Lee IH, Gean PW, Lee SY, Chi MH, Yang YK, Lu RB, Chen PS (2012) Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun 26:90–95PubMedCrossRef

Collerton D (2013) Psychotherapy and brain plasticity. Front Psychol 4:548PubMedCentralPubMedCrossRef

Constant EL, Adam S, Gillain B, Seron X, Bruyer R, Seghers A (2005) Effects of sertraline on depressive symptoms and attentional and executive functions in major depression. Depress Anxiety 21:78–89PubMedCrossRef

de Vries U, Schüßler G, Petermann F (2013) The neuropsychological principles of psychotherapy. Z Psychosom Med Psychother 59:301–310PubMed

Dobkin RD, Tröster AI, Rubino JT, Allen LA, Gara MA, Mark MH, Menza M (2014) Neuropsychological outcomes after psychosocial intervention for depression in Parkinson’s Disease. J Neuropsychiatr Clin Neurosci 26:57–63CrossRef

Elgamal S, McKinnon MC, Ramakrishnan K, Joffe RT, MacQueen G (2007) Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study. Psychol Med 37:1229–1238PubMedCrossRef

Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatr 59:425–433PubMedCrossRef

Galassi R, Di Sarro R, Morreale A, Amore M (2006) Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affect Disord 91:243–250CrossRef

Gawrysiak MJ, Swan SA, Nicholas CR, Rogers BP, Dougherty JH, Hopko DR (2013) Pragmatic psychodynamic psychotherapy for a patient with depression and breast cancer: functional MRI evaluation of treatment effects. Am J Psychother 67:237–255PubMed

Gladsjo JA, Rapaport MH, McKinney R, Lucas JA, Rabin A, Oliver T, Davis J, Auerbach M, Judd LL (1998) A neuropsychological study of panic disorder: negative findings. J Affect Disord 49:123–131PubMedCrossRef

Goeldner C, Ballard TM, Knoflach F, Wichmann J, Gatti S, Umbricht D (2013) Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target. Neuropharmacology 64:337–346PubMedCrossRef

Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatr 61:34–41PubMedCrossRef

Goldin PR, Ziv M, Jazaieri H, Hahn K, Heimberg R, Gross JJ (2013) Impact of cognitive behavioral therapy for social anxiety disorder on the neural dynamics of cognitive reappraisal of negative self-beliefs: randomized clinical trial. JAMA Psychiatr 70:1048–1056CrossRef

Gorenstein C, de Carvalho SC, Artes R, Moreno RA, Marcourakis T (2006) Cognitive performance in depressed patients after chronic use of antidepressants. Psychopharmacology 185:84–92PubMedCrossRef

Gualtieri CT, Johnson LG, Benedict KB (2006) Neurocognition in depression: patients on and off medication versus healthy comparison subjects. J Neuropsychiatry Clin Neurosci 18:217–225PubMedCrossRef

Han L, McCusker J, Cole M, Capek R, Abrahamowicz M (2011) Antidepressant use and cognitive functioning in older medical patients with major or minor depression: a prospective cohort study with database linkage. J Clin Psychopharmacol 31:429–435PubMedCentralPubMedCrossRef

Herrera-Guzmán I, Gudayol-Ferré E, Herrera-Guzmán D, Guàrdia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE (2009) Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res 43:855–863PubMedCrossRef

Herrera-Guzmán I, Herrera-Abarca JE, Gudayol-Ferré E, Herrera-Guzmán D, Gómez-Carbajal L, Peña-Olvira M, Villuendas-González E, Joan GO (2010) Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder. Psychiatr Res 177:323–329CrossRef

Hindmarch I (1998) Cognition and anxiety: the cognitive effects of anti-anxiety medication. Acta Psychiatr Scand Suppl 393:89–94PubMedCrossRef

Hindmarch I, Hashimoto K (2010) Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered. Hum Psychopharmacol 25:193–200PubMedCrossRef

Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Raczak A, Cubała WJ, Wiglusz MS, Herstowska M, Landowski J (2013) Impulsivity in panic disorder: neuropsychological correlates. Psychiatr Danub 25(Suppl 2):S149–S152PubMed

Kaneko K, Nakagome K (2011) A multi-channel near-infrared spectroscopy study of prefrontal cortex activation during working memory task in major depressive disorder. Neurosci Res 70:91–97PubMedCrossRef

Kaplan JS, Erickson K, Luckenbaugh DA, Weiland-Fiedler P, Geraci M, Sahakian BJ, Charney D, Drevets WC, Neumeister A (2006) Differential performance on tasks of affective processing and decision-making in patients with panic disorder and panic disorder with comorbid major depressive disorder. J Affect Disord 95:165–171PubMedCrossRef

Karch S, Heinzel S, Pogarell O, Schiepek G (2012) Neurobiological basis of psychotherapeutic approaches. Methodological demands and results for psychiatric disorder patterns. Psychotherapeut 57:204–212CrossRef

Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS (2007) Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatr 164:778–788PubMedCrossRef

Klasik A, Krysta K, Krupka-Matuszczyk I (2011) Effect of tianeptine on cognitive functions in patients with depressive disorders during a 3-month observation. Psychiatr Danub 23(Suppl 1):S18–S22PubMed

Klasik A, Krysta K, Krzystanek M (2012) Impact of psychotherapy and antidepressive treatment on cognitive functions in patients treated for depression. Psychiatr Danub 24(Suppl 1):S130–S134PubMed

Krzystanek M, Pałasz A, Krzystanek E, Krupka-Matuszczyk I, Wiaderkiewicz R, Skowronek R (2011) S-adenosyl l-methionine in CNS diseases. Psychiatr Pol 45:923–931PubMed

Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA (2012) A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord 140:113–124PubMedCrossRef

Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas GI (2012) Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. J Affect Disord 136:1174–1178PubMedCrossRef

Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological Assessment. Oxford University Press

Lindauer RJ, Booij J, Habraken JB, van Meijel EP, Uylings HB, Olff M, Carlier IV, den Heeten GJ, van Eck-Smit BL, Gersons BP (2008) Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial. Psychol Med 38:543–554PubMed

Mackin RS, Nelson JC, Delucchi K, Raue P, Byers A, Barnes D, Satre DD, Yaffe K, Alexopoulos GS, Arean PA (2013) Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction. Am J Geriatr Psychiatr. doi:10.1016/j.jagp.2013.11.002

McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, Alsuwaidan M, Baskaran A (2013) Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 30:515–527PubMedCrossRef

McLennan SN, Mathias JL (2010) The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatr Psychiatr 25:933–944CrossRef

Messina I, Sambin M, Palmieri A, Viviani R (2013) Neural correlates of psychotherapy in anxiety and depression: a meta-analysis. PLoS One 8(9):e74657PubMedCentralPubMedCrossRef

Morgiève M, N’diaye K, Haynes WI, Granger B, Clair AH, Pelissolo A, Mallet L (2013) Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging. Psychol Med 4:1–13

Naismith SL, Redoblado-Hodge MA, Lewis SJ, Scott EM, Hickie IB (2010) Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. J Affect Disord 121:258–262PubMedCrossRef

Novac A, Bota RG (2013) Transprocessing: neurobiologic mechanisms of change during psychotherapy-a proposal based on a case report. Perm J. doi:10.7812/TPP/12-045 PubMedCentralPubMed

Pae CU, Marks DM, Han C, Patkar AA (2008) Does minocycline have antidepressant effect? Biomed Pharmacother 62:308–311PubMedCrossRef

Pedrelli P, Baer L, Losifescu DV, Fava M (2010) Relationship between residual symptoms of depression and self-reported cognitive impairment. CNS Spectr 15:46–51PubMed

Pelton GH, Harper OL, Tabert MH, Sackeim HA, Scarmeas N, Roose SP, Devanand DP (2008) Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatr 23:670–676CrossRef

Prasko J, Horácek J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C (2004) The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants. Neuro Endocrinol Lett 25:340–348PubMed

Pu S, Yamada T, Yokoyama K, Matsumura H, Kobayashi H, Sasaki N, Mitani H, Adachi A, Kaneko K, Nakagome K (2011) A multi-channel near-infrared spectroscopy study of prefrontal cortex activation during working memory task in major depressive disorder. Neurosci Res 70:91–97PubMedCrossRef

Raczak A, Jakuszkowiak-Wojten K, Gałuszko-Węgielnik M, Cubała WJ, Wiglusz MS, Herstowska M, Landowski J (2013) Immediate and delayed visual memory and recognition in patients with panic disorders. Psychiatr Danub 25(Suppl 2):S146–S148PubMed

Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC (2007) Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatr 164:900–909PubMedCrossRef

Reinecke A, Waldenmaier L, Cooper MJ, Harmer CJ (2013) Changes in automatic threat processing precede and predict clinical changes with exposure-based cognitive-behavior therapy for panic disorder. Biol Psychiatr 73:1064–1070CrossRef

Roiser JP, Sahakian BJ (2013) Hot and cold cognition in depression. CNS Spectr 18:139–149PubMedCrossRef

Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T (2006) Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 33:218–226PubMedCrossRef

Schaub A, Neubauer N, Mueser KT, Engel R, Möller HJ (2013) Neuropsychological functioning in inpatients with major depression or schizophrenia. BMC Psychiatr 13:203CrossRef

Schiepek G, Tominschek I, Heinzel S, Aigner M, Dold M, Unger A, Lenz G, Windischberger C, Moser E, Plöderl M, Lutz J, Meindl T, Zaudig M, Pogarell O, Karch S (2013) Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reports. PLoS One 8:e71863PubMedCentralPubMedCrossRef

Schrijvers D, Maas YJ, Pier MP, Madani Y, Hulstijn W, Sabbe BG (2009) Psychomotor changes in major depressive disorder during sertraline treatment. Neuropsychobiology 59:34–42PubMedCrossRef

Stewart SA (2005) The effects of benzodiazepines on cognition. J Clin Psychiatr 66 Suppl 2:13–19

Talarowska M, Gałecki P, Maes M, Bobińska K, Kowalczyk E (2012) Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Neurochem Res 37:1761–1767PubMedCrossRef

Trivedi MH, Greer TL (2014) Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord 152–154:19–27PubMedCrossRef

Title: Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning
Authors: Krzysztof Krysta
Marek Krzystanek
Małgorzata Janas-Kozik
Adam Klasik
Irena Krupka-Matuszczyk
Publication date: 01-08-2015
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue Special Issue 1/2015
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-014-1282-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Impact of pharmacological and psychological treatment methods of depressive and anxiety disorders on cognitive functioning

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2015

Mechanisms underlying the neuroprotective effect of brain reserve against late life depression

Agomelatine: an agent against anhedonia and abulia?

Neurovascular remodeling in the aged ischemic brain

Polypharmacy in the treatment of subjects with intellectual disability

Integrating pharmacotherapy and psychotherapy

Diurnal rodents as an advantageous model for affective disorders: novel data from diurnal degu (Octodon degus)